Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
Now part of
Zydus Lifesciences Limited
ZYDUSLIFE
NSE
US subsidiary of Zydus Lifesciences, developing pharmaceutical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Liver drug study seeks to understand how body processes medication in scarred livers Results expected Dec 2026 (estimated)
- New drug study aims to understand how liver disease affects medication Results expected Dec 2026 (estimated)
- Hope for liver disease: new drug trial targets PBC symptoms Results expected Apr 2027 (estimated)